BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cell & Gene

PeproMene Bio Secures $11M Investment to Advance BAFF-R CAR T Therapy for Relapsed Follicular Lymphoma

Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive $6M USD upfront plus an addit...

December 20, 2024 | News

Nona Biosciences and Candid Therapeutics Collaborate to Advance Next-Generation T-Cell Engagers for Autoimmune Diseases

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced a research collaboration and lic...

December 17, 2024 | News

CellProthera and SKGH Forge Alliance to Advance CD34+ Cell Therapy for Ischemic Diseases in Japan

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakur...

December 13, 2024 | News

SK pharmteco Unifies Global Brands to Establish CDMO Powerhouse

SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy indu...

December 12, 2024 | News

Thermo Fisher Enhances Cell Therapy Manufacturing with CTS Detachable Dynabeads™ for CD4+ and CD8+ T Cell Isolation

T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing Thermo Fishe...

December 05, 2024 | News

South Korea’s S.BIOMEDICS Announces Promising Phase 1/2a Data for TED-A9 Cell Therapy in Parkinson’s Disease

-S.BIOMEDICS revealed promising one-year post-transplant data from their Phase 1/2a clinical trial of the TED-A9 cell therapy for Parkinson's disease....

November 27, 2024 | News

VectorBuilder and Sartorius Announce Strategic Partnership to Advance Gene Delivery and mRNA Bioprocess Solutions

VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in life science research and the biopha...

November 27, 2024 | News

GenScript Biotech Hosts European Debut of Global Forum, Driving Collaboration in Cell and Gene Therapy Innovation

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenS...

November 22, 2024 | Report

Acepodia Secures FDA IND Clearance for ACE1831, Pioneering Gamma Delta T Cell Therapy in Autoimmune Disease

IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program ACE1831 is an allogeneic gamma delta T...

November 18, 2024 | News

Teijin and Hilleman Laboratories Forge Strategic CDMO Partnership to Advance Cell and Gene Therapy in Asia-Pacific

Teijin Limited and Hilleman Laboratories, a biotechnology company based in Singapore, announced the signing of a Memorandum of Understanding...

October 31, 2024 | News

I Peace, Inc. Introduces HLA-Homozygous iPSC Line to Boost Compatibility and Accessibility in Allogenic Cell Therapies

I Peace, Inc., a leading GMP cell contract development and manufacturing organization (CDMO) specializing in induced pluripotent stem cells (iPSCs) and iPS...

October 30, 2024 | News

Medera Advances HFpEF Gene Therapy to High-Dose Cohort After Promising Results

Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing over US$100B per year Heart failure with preserved ...

October 25, 2024 | News

Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts

In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...

October 17, 2024 | Interview

Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio

Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development Av...

October 11, 2024 | News

Stay Connected